133 related articles for article (PubMed ID: 19649839)
1. High-throughput screening for lead optimization: a rational approach.
Bajpai M; Adkison KK
Curr Opin Drug Discov Devel; 2000 Jan; 3(1):63-71. PubMed ID: 19649839
[TBL] [Abstract][Full Text] [Related]
2. Applications of high-throughput ADME in drug discovery.
Kassel DB
Curr Opin Chem Biol; 2004 Jun; 8(3):339-45. PubMed ID: 15183334
[TBL] [Abstract][Full Text] [Related]
3. Compound optimization in early- and late-phase drug discovery: acceptable pharmacokinetic properties utilizing combined physicochemical, in vitro and in vivo screens.
Caldwell GW
Curr Opin Drug Discov Devel; 2000 Jan; 3(1):30-41. PubMed ID: 19649835
[TBL] [Abstract][Full Text] [Related]
4. Which in vitro screens guide the prediction of oral absorption and volume of distribution?
van de Waterbeemd H
Basic Clin Pharmacol Toxicol; 2005 Mar; 96(3):162-6. PubMed ID: 15733210
[TBL] [Abstract][Full Text] [Related]
5. Lead optimization strategies as part of a drug metabolism environment.
Korfmacher WA
Curr Opin Drug Discov Devel; 2003 Jul; 6(4):481-5. PubMed ID: 12951811
[TBL] [Abstract][Full Text] [Related]
6. High-throughput screening applied to drug synthesis process development.
Cannarsa MJ; Uno T; Larsen C
Curr Opin Drug Discov Devel; 2000 Nov; 3(6):743-9. PubMed ID: 19649902
[TBL] [Abstract][Full Text] [Related]
7. Drug selection in early drug development: screening for acceptable pharmacokinetic properties using combined in vitro and computational approaches.
Sinko PJ
Curr Opin Drug Discov Devel; 1999 Jan; 2(1):42-8. PubMed ID: 19649916
[TBL] [Abstract][Full Text] [Related]
8. In silico prediction of ADME properties: are we making progress?
Beresford AP; Segall M; Tarbit MH
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):36-42. PubMed ID: 14982146
[TBL] [Abstract][Full Text] [Related]
9. A review of high throughput technology for the screening of natural products.
Mishra KP; Ganju L; Sairam M; Banerjee PK; Sawhney RC
Biomed Pharmacother; 2008 Feb; 62(2):94-8. PubMed ID: 17692498
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening of biocatalytic activity: applications in drug discovery.
Kumar RA; Clark DS
Curr Opin Chem Biol; 2006 Apr; 10(2):162-8. PubMed ID: 16520085
[TBL] [Abstract][Full Text] [Related]
11. High-throughput pharmacokinetics: cassette dosing.
Bayliss MK; Frick LW
Curr Opin Drug Discov Devel; 1999 Jan; 2(1):20-5. PubMed ID: 19649913
[TBL] [Abstract][Full Text] [Related]
12. When poor solubility becomes an issue: from early stage to proof of concept.
Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
[TBL] [Abstract][Full Text] [Related]
13. HTS Technologies--IBC Informa Conference.
Kubinyi H
IDrugs; 2001 Feb; 4(2):168-73. PubMed ID: 16032477
[TBL] [Abstract][Full Text] [Related]
14. High-throughput human metabolism and toxicity analysis.
Lee MY; Dordick JS
Curr Opin Biotechnol; 2006 Dec; 17(6):619-27. PubMed ID: 17046235
[TBL] [Abstract][Full Text] [Related]
15. Validation of a high-throughput absorption, distribution, metabolism, and excretion (ADME) system and results for 60 literature compounds.
Yan Z; Lu C; Wu JT; Elvebak L; Brockman A
Rapid Commun Mass Spectrom; 2005; 19(9):1191-9. PubMed ID: 15818724
[TBL] [Abstract][Full Text] [Related]
16. [New methods in pharmaceutical research: combinatorial chemistry and high throughput screening].
Schirlin D; Galvan M; Le Fur G
Bull Acad Natl Med; 2007; 191(4-5):727-36; discussion 736-7. PubMed ID: 18225426
[TBL] [Abstract][Full Text] [Related]
17. In silico pharmacology for a multidisciplinary drug discovery process.
Ortega SS; Cara LC; Salvador MK
Drug Metabol Drug Interact; 2012; 27(4):199-207. PubMed ID: 23152402
[TBL] [Abstract][Full Text] [Related]
18. Applications of physiologically based absorption models in drug discovery and development.
Parrott N; Lave T
Mol Pharm; 2008; 5(5):760-75. PubMed ID: 18547054
[TBL] [Abstract][Full Text] [Related]
19. Novel trends in high-throughput screening.
Mayr LM; Bojanic D
Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
[TBL] [Abstract][Full Text] [Related]
20. The use of informatics and automation to remove bottlenecks in drug discovery.
Calvert S; Stewart FP; Swarna K; Wiseman JS
Curr Opin Drug Discov Devel; 1999 May; 2(3):234-8. PubMed ID: 19649951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
